[Ip-health] India's Minister for Commerce and Industry on Novartis Patent Ruling

Hafiz Aziz-ur- Rehman aziz76pk at yahoo.com
Thu Apr 11 05:48:51 PDT 2013

Thanks Brook but that segment does not fully capture the breadth of all questions asked about Novartis case and Indian patent law so I decided to share the full version. Anyhow good for those who have less time (means almost all of us!)



 From: "Baker, Brook" <b.baker at neu.edu>
To: Hafiz Aziz-ur- Rehman <aziz76pk at yahoo.com>; "ip-health at lists.keionline.org" <ip-health at lists.keionline.org> 
Sent: Thursday, 11 April 2013 2:40 PM
Subject: Re: [Ip-health] India's Minister for Commerce and Industry on Novartis Patent Ruling

The specific segment can be found at:

Professor Brook K. Baker

Health GAP (Global Access Project)
Northeastern U. School of Law
Program on Human Rights and the Global Economy
400 Huntington Ave.
Boston, MA 02115 USA
Honorary Research Fellow, University of KwaZulu Natal, Durban, S. Africa
(w) 617-373-3217
(cell) 617-259-0760
(fax) 617-373-5056
b.baker at neu.edu

On 4/11/13 4:14 AM, "Hafiz Aziz-ur- Rehman" <aziz76pk at yahoo.com> wrote:

>Minister Sharma said that Novartis is the third largest beneficiary of
>registration of  patents
>>in India (Pharmaceutical) with 147 patents granted...
>>India's Minister for Commerce and Industry Anand Sharma comments on the
>>Novartis patent ruling by the Indian Supreme Court at a WIPO press
>>conference on April 8, 2013, following a High Level Policy Dialogue with
>>the Geneva diplomatic community where he spoke on the subject
>>"Innovation and Development: The Indian Experience."
>Hafiz Aziz ur Rehman, Ph.D.
>Legal & Policy Advisor
>Médecins Sans Frontières - Access Campaign
>Rue de Lausanne 78
>1211 Geneva, Switzerland
>azeez.rehman at gmail.com
>Skype: rehmanh
>Follow us on Twitter:  http://twitter.com/MSF_access
>Join us on http://www.facebook.com/MSFaccess
>Ip-health mailing list
>Ip-health at lists.keionline.org

More information about the Ip-health mailing list